Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Owkin is a French-American AI biotechnology company that specializes in applying artificial intelligence and federated learning to drug discovery, drug development, and diagnostics. Their mission is to connect the global healthcare ecosystem through a privacy-preserving, collaborative research platform. By analyzing vast amounts of patient data from leading academic medical centers and pharmaceutical companies, Owkin aims to identify novel drug targets, predict treatment efficacy, develop advanced diagnostic tools, and ultimately accelerate the development of new therapies for critical diseases like cancer and cardiovascular conditions.
Serves as the central hub for global operations, strategic leadership, core research and development in AI and federated learning, and coordination of international collaborations.
Modern office space located in a prestigious district of Paris, designed to foster innovation and collaboration among its diverse teams of scientists, engineers, and medical experts.
Characterized by a highly innovative, research-intensive, and collaborative environment. Employees (Owkinites) are mission-driven, focusing on leveraging cutting-edge AI to make a significant impact on patient care. The culture is international and values scientific rigor.
The Paris headquarters is the primary node for Owkin's pioneering work in AI for healthcare and symbolizes its strong French origins combined with its global ambitions in the biotechnology sector. It's central to their European operations and research partnerships.
Owkin supports its global operations through its headquarters in Paris and key offices in New York, London, Boston, and Nantes. Its functions, including AI research, data science, business development, and partnership management, are distributed across these strategic locations to effectively collaborate with a worldwide network of academic medical centers, research institutions, and pharmaceutical companies. Owkin's federated learning model allows for secure, collaborative research across international borders, enabling a truly global impact on drug discovery and patient care.
12 Rue de Presbourg
Paris
Île-de-France
France
Address: 60 East 42nd Street, Suite 4600, New York, NY 10165
To strengthen presence in the major US biotech and pharma ecosystem, facilitating partnerships and access to data networks.
Address: The Hickman, 2 Whitechapel Rd, London E1 1EW
Leverages London's position as a leading center for medical research and AI innovation to expand Owkin's federated learning network.
Address: 1 Broadway, Cambridge, MA 02142 (Kendall Square)
To tap into the dense ecosystem of biotech companies, research institutions, and talent in the Greater Boston area.
Address: 6 Rue Rose Dieng-Kuntz, 44300 Nantes
To access a strong local tech talent pool and support Owkin's core technology development initiatives in France.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, OWKIN' leadership includes:
OWKIN has been backed by several prominent investors over the years, including:
Publicly announced C-suite executive changes at Owkin have been limited in the immediate past 12 months (approx. May 2023 - May 2024). The company has focused on strengthening its scientific advisory board and continues to build out its leadership team as it scales. Information on specific C-level hires or exits is not widely publicized.
Discover the tools OWKIN uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Owkin commonly uses the 'first.last' email format for its employees. Other variations might exist but this is a widely observed pattern.
[first].[last]@owkin.com
Format
thomas.clozel@owkin.com
Example
90%
Success rate
Sanofi Press Release • April 24, 2024
Sanofi and Owkin announced an expansion of their existing partnership in immunology to include programs in autoimmune diseases. This multi-year collaboration aims to leverage Owkin’s AI capabilities to identify new therapeutic targets and enhance clinical trial design for these conditions, building on their previous successes in oncology....more
Owkin Newsroom • November 16, 2023
Owkin announced that its AI-driven diagnostic solution, RlapsRisk BC, has received CE-IVD marking in Europe. This tool is designed to predict the risk of relapse in patients with early-stage breast cancer by analyzing digital pathology slides, aiding clinicians in personalizing treatment strategies....more
Owkin Newsroom • February 27, 2024
Owkin announced the appointment of Professor Charles Swanton and Professor John Marioni to its Strategic Advisory Board (SAB). These leading experts in oncology, genomics, and computational biology will provide strategic guidance to enhance Owkin's research and development efforts in AI-driven drug discovery and diagnostics....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including OWKIN, are just a search away.